Akari Therapeutics, Plc (AKTX), a biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune and inflammatory diseases where the complement and/or leukotriene systems are implicated, today announced that it has entered into definitive agreements with certain accredited investors, the majority of whom are existing Akari Therapeutics Plc - AKTX - Stock Price Today - Zacks View Akari Therapeutics PLC AKTX investment & stock information. Get the latest Akari Therapeutics PLC AKTX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. AKTX | Akari Therapeutics PLC ADR Profile | MarketWatch Nov 06, 2019 · Akari Therapeutics PLC ADR company facts, information and stock details by MarketWatch. View aktx business summary and other industry information. AKTX Stock Price, Forecast & News (Akari Therapeutics)
View today's stock price, news and analysis for Akari Therapeutics PLC ADR ( AKTX). Barron's also provides information on historical stock ratings, target prices , Akari Therapeutics Plc stock and Biotechnology market discussion, news, and analysis from Canada's largest community of active investors.
Records 1 - 18 of 21 Get up to 10 years of daily historical stock prices & volumes. Data provided by Edgar Online. ©2019, EDGAR®Online, a division of Donnelley
AKTX Stock Price, Forecast & News (Akari Therapeutics) Akari Therapeutics' stock was trading at $1.54 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, AKTX stock has decreased by 16.2% and is now trading at $1.29. Akari Therapeutics - Stock Price History | AKTX | MacroTrends The latest closing stock price for Akari Therapeutics as of February 07, 2020 is 1.80. The all-time high Akari Therapeutics stock closing price was 31.50 on September 21, 2015. The Akari Therapeutics 52-week high stock price is 9.20, which is 411.1% above the current share price. AKARI THERAPEUTICS PLC - AKTX - Stock Price & News | The ...
Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of treatments for a range of rare and orphan autoimmune and inflammatory diseases.